Bill > HR1587

This bill, the "Making Insulin Affordable for All Children Act," aims to provide appropriate cost-sharing for individuals 26 years of age or younger for insulin products covered under private health plans and Medicaid. The key provisions of the bill are: 1) For private health plans, it prohibits the application of any deductible and limits cost-sharing to the lesser of $35 or 25% of the negotiated price for selected insulin products for individuals 26 and under; 2) For Medicaid, it prohibits the application of any deductible and limits cost-sharing to the lesser of $35 or 25% of the negotiated price for selected insulin products for individuals 26 and under. The bill defines "selected insulin products" as at least one of each dosage form and type of insulin licensed and marketed under the Public Health Service Act.